| 学科主题 | 临床医学 |
| EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS | |
| Zhou, C.1; Wu, Y-L.2,3; Chen, G.4; Feng, J.5; Liu, X.6; Wang, C.7; Zhang, S.8; Wang, J.9; Zhou, S.1; Ren, S.1; OPTIMAL Investigators | |
| 刊名 | ANNALS OF ONCOLOGY
 |
| 2010-10-01 | |
| 卷 | suppl.8页:6-6 |
| 收录类别 | SCI ; ISTP |
| 文章类型 | Meeting Abstract |
| WOS标题词 | Science & Technology |
| 类目[WOS] | Oncology |
| 研究领域[WOS] | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000283115900014 |
| Citation statistics | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.bjmu.edu.cn/handle/400002259/55553 |
| Collection | 北京大学临床肿瘤学院 |
| 作者单位 | 1.Beijing Chest Hosp, Beijing, Peoples R China 2.Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China 3.Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China 4.Harbin Med Coll, Canc Hosp, Harbin, Peoples R China 5.Jiangsu Prov Canc Hosp, Nanjing, Peoples R China 6.Tianjin Canc Hosp, Tianjin, Peoples R China 7.Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China 8.Acad Mil Med Sci, Hosp 307, Ctr Canc, Beijing, Peoples R China 9.Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China |
| Recommended Citation GB/T 7714 | Zhou, C.,Wu, Y-L.,Chen, G.,et al. EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS[J]. ANNALS OF ONCOLOGY,2010,suppl.8:6-6. |
| APA | Zhou, C..,Wu, Y-L..,Chen, G..,Feng, J..,Liu, X..,...&OPTIMAL Investigators.(2010).EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS.ANNALS OF ONCOLOGY,suppl.8,6-6. |
| MLA | Zhou, C.,et al."EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS".ANNALS OF ONCOLOGY suppl.8(2010):6-6. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment